Tesofensine (250mcg) / Dihexa (10mg) x 60 Tablets

• Composition and format
Tesofensine (250 mcg) / Dihexa (10 mg) is a fixed-combination research formulation supplied as solid-format tablets for controlled laboratory workflows. Each tablet contains 250 mcg of tesofensine and 10 mg of dihexa, with 60 tablets per container. The batch-specific Certificate of Analysis (COA) documents active-component identities, per-tablet content verification, physical characteristics, and relevant excipient information to support reproducibility, mass-balance calculations, and documentation control in research environments.

• Analytical verification
Each production lot is qualified at 99%+ purity by high-performance liquid chromatography, with compound identities confirmed by mass spectrometry. Independent third-party laboratories corroborate in-house analytical results to maintain traceable quality metrics appropriate for research use.

• Intended research use
Tesofensine / Dihexa is evaluated exclusively in controlled in-vitro systems investigating monoaminergic signaling dynamics, neurotrophic pathway modulation, and synaptic signaling models under defined assay conditions. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.

• Research characteristics and applications
This multi-analyte formulation is characterized for use as a research tool in analytical and cell-based models examining interactions between neurotransmitter reuptake modulation and hepatocyte growth factor–related signaling pathways. In controlled in-vitro environments, researchers employ the formulation to study synaptic signaling behavior, receptor- and transporter-associated responses, neuroplasticity-related pathway activation, and pathway cross-talk between small-molecule and peptide-mimetic components. Representative applications include assay development, comparative concentration-response profiling, time-course analyses, and mechanistic investigations of neurochemical signaling strictly within laboratory settings.

• Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. Certificates of Analysis, raw-material sourcing from vetted suppliers, and complete batch documentation are maintained to support institutional procurement review, traceability, and audit readiness.